$35M QVAR Inhaler Settlement Resolves Teva Pharmaceuticals Antitrust Lawsuit

$35M QVAR Inhaler Settlement Resolves Teva Pharmaceuticals Antitrust Lawsuit

This settlement is closed. The claim deadline has passed and new claims are no longer being accepted. This page is kept for reference — see settlements that are still open →

By the Class Action Buddy Editorial Team · Last reviewed May 12, 2026

See details
Max Payout
Jul 31, 2026
Filing Deadline
See Details
Proof Required?
Teva Pharmaceuticals has agreed to a $35 million settlement to resolve a class action lawsuit over its QVAR inhaler products. The lawsuit alleged that Teva illegally tried to block competition for its QVAR inhalers, which may have kept prices artificially high for consumers. If you purchased or used QVAR inhalers, you may be entitled to compensation from this settlement. The lawsuit claims Teva engaged in anticompetitive practices that harmed consumers who relied on these important asthma medications.
🎯

Looking for a settlement you can still file?

This one is closed, but our 60-second eligibility quiz finds the ones that are still open.

Check Eligibility →

Who Was Eligible?

Who the settlement covered:

  • Purchased QVAR inhalers during the relevant time period
  • Used QVAR inhaler products that may have been affected by the alleged anticompetitive practices
  • Paid higher prices due to Teva's alleged blocking of generic competition
  • Specific eligibility dates and requirements are still being determined

How Much Did It Pay?

The total settlement fund is $35 million, which will be distributed among qualifying class members. The exact amount each person can receive depends on factors like how many QVAR inhalers they purchased and during what time period. Individual payouts will be calculated based on the final settlement terms and the total number of valid claims submitted.

How this claim was filed

This settlement is closed, so the steps below are kept for reference only — they no longer lead anywhere you can file.

  • Wait for the court to approve the final settlement terms
  • Watch for official notice about claim filing procedures
  • Gather records of your QVAR inhaler purchases if available
  • Submit your claim before the deadline once filing opens

Looking for something you can still claim?

This one has closed, but the open settlements list is kept current, and Class Action Buddy will tell you when a new one matches your profile.

Frequently Asked Questions

What is the deadline to file a claim for the $35M QVAR Inhaler Settlement Resolves Teva Pharmaceuticals Antitrust Lawsuit?

The deadline to file a claim was Jul 31, 2026, and it has passed. Claims are no longer accepted for this settlement.

What is the QVAR inhaler settlement about?

The settlement resolves claims that Teva Pharmaceuticals illegally blocked competition for its QVAR inhaler products, potentially keeping prices higher than they should have been.

How much money can I get from the QVAR settlement?

Individual payouts from the $35 million settlement fund will depend on factors like how many inhalers you purchased and the total number of claims filed. Specific amounts are still being determined.

Do I need receipts to claim QVAR settlement money?

While purchase records would be helpful, the specific documentation requirements haven't been announced yet. Check back for updates on what proof may be needed to file your claim.

Primary source: official settlement administrator — qvarantitrustsettlement.com. The settlement details on this page were checked against the administrator’s official website.

Class Action Buddy is an independent directory and is not affiliated with, endorsed by, or sponsored by the settlement administrator or the court. This page is general information, not legal advice. See how we verify settlements.

This settlement has closed

The filing deadline for this one has passed, so no new claims are being accepted. Class Action Buddy tracks the settlements that are still open and tells you when a new one matches your profile.

See settlements that are open →